DIE TECHNOLOGY LIMITED

Company number 01755336 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: DIE TECHNOLOGY LIMITED

1. Financial Health Score: C – Satisfactory for a Dormant Entity, but with Chronic Underlying Weakness

Explanation: This company is not trading – it's a dormant shell. In medical terms, it's in a stable coma: no vital signs of life (no revenue, no activity), but also no immediate threat of death. The score reflects that while statutory compliance is fine and there are no debts, the company carries a significant historical loss of -£154,200 that signals past serious financial trauma. For a dormant company, this is acceptable, but for an active business, it would be a critical condition.

2. Key Vital Signs

Vital Sign Reading Interpretation
Net Assets £0 Flatline – no surplus or deficit. Technically solvent but with zero cushion.
Shareholders' Funds (Equity) £0 (after offsetting reserves) The balance sheet balances at zero, meaning all past losses have consumed any original capital surplus.
Profit & Loss Reserve -£154,200 A chronic haemorrhage of retained losses that has never been healed.
Share Capital & Premium £113,371 total This was the original "blood supply" injected into the body, now completely absorbed by losses.
Current Liabilities None shown No short-term debts – no immediate payment stress.
Turnover/Revenue £0 No business activity – the patient is in a medically induced coma.
Filing Compliance Up to date The company is meeting statutory obligations – a sign of administrative health.

3. Diagnosis: Chronic Dormancy with Historical Capital Erosion

  • Primary Condition: The company is dormant (SIC 99999). It has no trading activity, no employees, and no operational cash flow.
  • Underlying Disease: A substantial accumulated loss of -£154,200 that has completely wiped out the original share capital and share premium. For a dormant company, this is not fatal because there are no new losses, but it indicates that in the past this company sustained significant financial damage (likely from trading losses or write-downs). The body has not recovered from that trauma.
  • Current Stability: No debts, no creditors, net assets at zero. The company is not insolvent because it has no liabilities exceeding its assets. It is sustained by being a wholly owned subsidiary of Micross Components Ltd / Corfin Holdings Inc – effectively on life support from its parent group.
  • Risk Indicators: The negative retained earnings is a red flag that would prevent the company from ever paying dividends or returning capital to shareholders. If the parent ever withdraws support (e.g., by ceasing to fund any minimal costs), the company could quickly become insolvent.

4. Recommendations: Actions to Improve Financial Wellness

  1. Clarify Purpose – "Is This Patient Needed?"
    The directors should formally assess why the company remains dormant. If it holds no intellectual property, contracts, or assets, there is no medical reason to keep it alive. A voluntary strike-off (dissolution) would be the cleanest outcome, ending ongoing filing costs and administrative burden.

  2. Eliminate the Historical Loss (Capital Reconstruction)
    If the company will be retained for future use (e.g., as a holding vehicle), consider a capital reduction to write off the -£154,200 P&L reserve against share premium or capital redemption reserve. This would clean the balance sheet and show a more healthy equity position. This requires a solvency statement and court or shareholder approval.

  3. Maintain Compliance Vigilance
    Continue to file dormant accounts on time and keep the confirmation statement up to date. A missed filing could revive penalties and risk strike-off – the equivalent of a preventable hospital readmission.

  4. Ensure Parental Support
    Since the company has no cash or income, any administrative costs (e.g., filing fees, accountant costs) must be covered by the ultimate parent, Micross Components Ltd / Corfin Holdings Inc. The directors should confirm that this funding line is secure.

  5. Monitor for Any Signs of Life
    If the company becomes active again (trades, employs people, holds assets), the accumulated loss will immediately impact the balance sheet. At that point, a full financial resuscitation plan (turnaround strategy, capital injection, or profit generation) would be needed to avoid sliding into insolvency.


Prognosis:
Stable but not healthy. As a dormant company, there is no present crisis, and no immediate risk of insolvency provided the parent continues basic support. However, the historical loss of -£154,200 means the company has no equity buffer. Any future trading would start with a significant deficit. Without a capital reconstruction or fresh capital, the company is not fit for operational life. The outlook is neutral – no growth, no decay – but the underlying condition limits any future options.

Perspective: Financial Health Diagnostician · Model: deepseek/deepseek-v4-flash · Generated 5 October 2026